Inovio Pharmaceuticals Inc. Stock Slips 5.1%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. slipped 5.1% to $1.11 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.

This was the stock's fifth consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 59.2% short of its 52-week high of $2.72, which the company achieved on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $267.57, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. remained unchanged.

Trading volume totaled 3.0 million, compared to the 50-day average of 4.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 29, 2026 16:32 ET (20:32 GMT)